|
Catalog Number S220GH |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problem
Pain (1994)
|
Event Date 06/10/2014 |
Event Type
Injury
|
Event Description
|
It has been reported that a patient with hepatocellular carcinoma (stage iii) developed an acute pancreatitis immediately after trans arterial embolisation (tae) performed near to the gastroduodenal artery with the device (embosphere microspheres).On the same day, the patient was placed on nil per os status in consideration of the risk of ischemic pancreatitis developing as a complication, since a small amount of embosphere seemed to have flown back.Epigastric pain developed soon after treatment.The patient also had strong queasiness and vomiting.The symptoms exacerbated and bth pancreatic amylase and lipase levels increased.Then the symptoms improved after futhan (nafamostat mesilate) administration and fasting.On (b)(6), patient started oral intake.On (b)(6) patient was discharged from the hospital.
|
|
Manufacturer Narrative
|
Nothing is expected to be returned for evaluation.Since the lot number was not provided, the device history record and complaint database could not be reviewed for similar issues.The instructions for use provide a warning to pay careful attention for signs of mis-targeted embolization.During injection, it is required to carefully monitor patient vital signs to include sao2 (e.G.Hypoxia, en changes).And consider terminating the procedure, investigating for possible shunting, or increasing microsphere size if any signs of mis-targeting occur or patient symptoms develop.Merit is unable to determine a root cause.
|
|
Search Alerts/Recalls
|
|
|